Clinical Trial Update: Interferon Gamma for Drug Resistant Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Interferon Gamma for drug-resistant pneumonia and pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Pulmonary Tuberculosis

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED